AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAY 5 - (NewsRx.com & NewsRx.net) -- Novavax, Inc., (NVAX) announced the appointment of Rahul Singhvi, DSc, to the newly created position of vice president, pharmaceutical development and manufacturing operations.
Singhvi will report to Nelson M. Sims, president and CEO.
Singhvi joins Novavax following 10 years' experience with Merck & Co. Most recently he served in the Merck manufacturing division as director, vaccine and sterile operations.
"We are pleased to attract someone of the caliber of Rahul Singhvi," said Sims. "Rahul is unique with a strong manufacturing background, a mastery of the sciences, and a strong business acumen that I believe is critical to success in the biopharmaceutical field. Rahul has built a track record ...